Vincenzo Pizzuti

Dr. Vincenzo Pizzuti

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2016 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
JAJonathan D. Ashley
Jonathan D. Ashley
CQCharissa J. Quinlan
Charissa J. Quinlan
VSValerie A. Schroeder
Valerie A. Schroeder
MSMark A. Suckow
Mark A. Suckow
VPVincenzo Pizzuti
Vincenzo Pizzuti
BBBasar Bilgicer
Basar Bilgicer
Here, we report the synthesis and evaluation of dual drug–loaded nanoparticles as an effective means to deliver carfilzomib and doxorubicin to multiple myeloma tumor cells at their optimal synergistic ratio. First, various molar ratios of carfilzomib to doxorubicin were screened against multiple myeloma cell lines to determine the molar ratio that elicited the greatest synergy using the Chou–Talalay method. The therapeutic agents were then incorporated into liposomes at the optimal synergistic ratio of 1:1 to yield dual drug–loaded nanoparticles with a narrow size range of 115 nm and high reproducibility. Our results demonstrated that the dual drug–loaded liposomes exhibited synergy in vitro and were more efficacious in inhibiting tumor growth in vivo than a combination of free drugs, while at the same time reducing systemic toxicity. Taken together, this study presents the synthesis and preclinical evaluation of dual drug–loaded liposomes containing carfilzomib and doxorubicin for enhanced therapeutic efficacy to improve patient outcome in multiple myeloma. Mol Cancer Ther; 15(7); 1452–9. ©2016 AACR.

1 June 2019 in Journal of Controlled Release
Verified
Journal Article
Closed access
RMRahul Misra
Rahul Misra
KSKaustabh Sarkar
Kaustabh Sarkar
JLJaewon Lee
Jaewon Lee
VPVincenzo Pizzuti
Vincenzo Pizzuti
DLDeborah S. Lee
Deborah S. Lee
YWYou-Yeon Won
You-Yeon Won

13 April 2016 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
PDPeter E Deak
Peter E Deak
MVMaura Vrabel
Maura Vrabel
VPVincenzo Pizzuti
Vincenzo Pizzuti
TKTanyel Kiziltepe
Tanyel Kiziltepe
BBBasar Bilgicer
Basar Bilgicer
Degranulation caused by type I hypersensitivity (allergies) is a complex biophysical process, and available experimental models for studying relevant immunoglobulin E binding epitopes on allergen proteins lack the ability to adequately evaluate, rank, and associate these epitopes individually and with each other. In this study, we propose a new allergy model system for studying potential allergen epitopes using nanoallergens, liposomes modified to effectively display IgE binding epitopes/haptens. By utilizing the covalently conjugated lipid tails on two hapten molecules (dinitrophenol and dansyl), hapten molecules were successfully incorporated into liposomes with high precision to form nanoallergens. Nanoallergens, with precisely controlled high-particle valency, can trigger degranulation with much greater sensitivity than commonly used bovine serum albumin conjugates. In rat basophil leukemia cell experiments, nanoallergens with only 2% hapten loading were able to trigger degranulation in vitro at concentrations as low as 10 pM. Additionally, unlike bovine serum albumin-hapten conjugates, nanoallergens allow exact control over particle size and valency. By varying the nanoallergen parameters such as size, valency, monovalent affinity of hapten, and specific IgE ratios, we exposed the importance of these variables on degranulation intensity while demonstrating nanoallergens’ potential for evaluating both high- and low-affinity epitopes. The data presented in this article establish nanoallergen platform as a reliable and versatile allergy model to study and evaluate allergen epitopes in mast cell degranulation.

26 February 2018 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
SJSung Duk Jo
Sung Duk Jo
JLJaewon Lee
Jaewon Lee
MJMin Kyung Joo
Min Kyung Joo
VPVincenzo Pizzuti
Vincenzo Pizzuti
NSNicholas J. Sherck
Nicholas J. Sherck
YWYou-Yeon Won
You-Yeon Won

9 July 2020 in ACS Applied Bio Materials
Verified
Journal Article
Closed access
VPVincenzo Pizzuti
Vincenzo Pizzuti
DVDhushyanth Viswanath
Dhushyanth Viswanath
STSandra E. Torregrosa-Allen
Sandra E. Torregrosa-Allen
MCMelanie P. Currie
Melanie P. Currie
BEBennett D. Elzey
Bennett D. Elzey
YWYou-Yeon Won
You-Yeon Won

12 August 2019 in ACS Biomaterials Science & Engineering
Verified
Journal Article
Closed access
VPVincenzo Pizzuti
Vincenzo Pizzuti
RMRahul Misra
Rahul Misra
JLJaewon Lee
Jaewon Lee
STSandra E. Torregrosa-Allen
Sandra E. Torregrosa-Allen
MCMelanie P. Currie
Melanie P. Currie
YWYou-Yeon Won
You-Yeon Won